LISAvienna: New edition available online

Our first newsletter in 2021 for example includes links to news items from Boehringer Ingelheim, CeMM, IMBA, Medicus.ai, MedUni Wien, Panoptes, P+F, UpNano, Valneva, ViennaLab and Viravaxx.

In our newsletter, you can learn more about funding opportunities, events and life sciences news from Vienna.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.